UBS Group
BVS icon

UBS Group’s Bioventus BVS Stock Holding History

UBS Group’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Buy
69,683
+5,787
+9% +$55.3K ﹤0.01% 6065
2026
Q1 		$583K Sell
63,896
-17,769
-22% -$149K ﹤0.01% 5974
2025
Q4 		$608K Buy
81,665
+9,705
+13% +$69.8K ﹤0.01% 5961
2025
Q3 		$481K Sell
71,960
-15,653
-18% -$109K ﹤0.01% 6118
2025
Q2 		$580K Buy
87,613
+41,441
+90% +$294K ﹤0.01% 5884
2025
Q1 		$422K Buy
46,172
+7,682
+20% +$76.7K ﹤0.01% 5984
2024
Q4 		$404K Buy
38,490
+4,114
+12% +$48.7K ﹤0.01% 5991
2024
Q3 		$411K Buy
34,376
+21,600
+169% +$187K ﹤0.01% 5364
2024
Q2 		$73.5K Buy
12,776
+11,471
+879% +$62.9K ﹤0.01% 6395
2024
Q1 		$6.79K Sell
1,305
-1,071
-45% -$5.23K ﹤0.01% 7435
2023
Q4 		$12.5K Sell
2,376
-1,902
-44% -$7.53K ﹤0.01% 7347
2023
Q3 		$14.1K Buy
4,278
+2,469
+136% +$8.66K ﹤0.01% 6967
2023
Q2 		$5.23K Sell
1,809
-13,918
-88% -$26.7K ﹤0.01% 7461
2023
Q1 		$16.8K Buy
15,727
+2,983
+23% +$5.71K ﹤0.01% 7210
2022
Q4 		$33.3K Buy
12,744
+5,372
+73% +$23.5K ﹤0.01% 7132
2022
Q3 		$51K Buy
7,372
+3,462
+89% +$27.1K ﹤0.01% 6332
2022
Q2 		$27K Sell
3,910
-1,198
-23% -$12.2K ﹤0.01% 6501
2022
Q1 		$72K Sell
5,108
-8,485
-62% -$114K ﹤0.01% 6145
2021
Q4 		$197K Buy
+13,593
New +$193K ﹤0.01% 5707
2021
Q3 		– Sell
-1,753
Closed -$31K – 9558
2021
Q2 		$31K Sell
1,753
-2,535
-59% -$40.9K ﹤0.01% 6877
2021
Q1 		$66K Buy
+4,288
New +$61.1K ﹤0.01% 6275

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group's BVS Position: Q2 2026 in Review

UBS Group increased its Bioventus (BVS) stake by 9.1% in Q2 2026, buying an estimated $55.3K and bringing the position to 69,683 shares worth $658K. The position accounts for ﹤0.01% of the portfolio, ranked #6065.

UBS Group first reported a position in BVS in Q1 2021 and has held it in 21 quarters since. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • UBS Group held 69,683 shares of Bioventus worth $658K as of Q2 2026.
  • UBS Group bought 5,787 Bioventus shares in Q2 2026, an estimated $55.3K.
  • Bioventus made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6065 holding.
  • UBS Group first reported a position in Bioventus in Q1 2021 and has held it in 21 quarters since.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.